A method for treating a subject comprising administering n-ethyl-n - fenil1,2 - dihydroxy-4 - hodroxi - 5 - Chloro - 1 - methyl - 2 - 3 - oxoquinolina - carboxamide optionally deuterated,For the treatment of autoimmune disease； a mixture thereof, Pharmaceutical Composition and its Preparation Process.

• 收藏
• 分享

专利权人:

TEVA PHARMACEUTICAL INDUSTRIES LTD.

发明人:

PIRYATINSKY VICTOR,LAXER AVITAL

申请号：

CL2013000063

公开号：

CL2013000063A1

申请日:

2013.01.08

申请国别(地区):

CL

年份:

2013

代理人:

摘要：

A method for treating a subject comprising administering n-ethyl-n - fenil1,2 - dihydroxy-4 - hodroxi - 5 - Chloro - 1 - methyl - 2 - 3 - oxoquinolina - carboxamide optionally deuterated,For the treatment of autoimmune disease； a mixture thereof, Pharmaceutical Composition and its Preparation Process.<；p>；Un mé；todo para tratar a un sujeto que comprende administrar n-etil-n-fenil1,2-dihidroxi-4-hodroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida opcionalmente deuterada, para el tratamiento de una enfermedad autoinmunitaria； una mezcla de los mismos； composició；n farmacé；utica y su proceso de preparació；n.<；/p>；

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/